ASCO Genitourinary Cancers Symposium


 

ASCO GU 2022 on Cabozantinib in Advanced RCC After the Failure of CPI Therapy: Final Analysis of a Non-Interventional CaboCHECK Study

37 views
February 24, 2022
0 Comments
Login to view comments. Click here to Login